# Mirum Pharmaceuticals (MIRM): value investors who own it

1 value investor held Mirum Pharmaceuticals in their Q3 2026 13F, led by Polen Capital Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Polen Capital Management | 0.0% | $2.4m | Added +1.8% | 5 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-14 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sold | 9943 | $978k |
| 2026-09-02 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sold | 658 | $66k |
| 2026-09-01 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sold | 21688 | $2.1m |
| 2026-09-01 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sold | 8312 | $815k |
| 2026-08-18 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sold | 40000 | $4.0m |
| 2026-08-11 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sold | 6001 | $600k |
| 2026-08-10 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sold | 11683 | $1.2m |
| 2026-08-10 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sold | 6017 | $597k |
| 2026-08-10 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sold | 2300 | $230k |
| 2026-08-03 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sold | 1840 | $194k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/mirm). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.